跳至主要内容
临床试验/IRCT20110411006168N4
IRCT20110411006168N4尚未招募未知

Investigating the effectiveness of adding Clonidine and Gabapentin to Buprenorphine during detoxification of children and adolescents with Opioid Use Disorders

Kerman University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
5 years 至 18 years(—)
性别
All

入选标准

  • Diagnosis of opioid use disorder based on DSM-5 by a child and adolescent psychiatrist
  • age 5-18 years old

排除标准

  • Allergy to buprenorphine or clonidine or gabapentin.
  • Chronic or inflammatory diseases (heart, lung, liver, kidney or neurological diseases such as epilepsy).
  • Serious psychiatric illnesses such as schizophrenia and other psychotic disorders, acute phase of bipolar disorder and moderate to severe mental disability.
  • Dissatisfaction of the patient's parent or Legal guardian to continue the plan.

研究者

相似试验

Investigating the effectiveness of adding Clonidine... | 临床试验